Literature DB >> 12650948

Serum iron levels in schizophrenic patients with or without akathisia.

Murat Kuloglu1, Murad Atmaca, Bilal Ustündag, Halit Canatan, Omer Gecici, Ertan Tezcan.   

Abstract

The pathophysiology of akathisia still remains controversial. Iron deficiency was proposed to be an important factor in the development of akathisia. In the present study, it was aimed to compare levels of serum iron and linked variables in chronic akathisic (n=30), and non-akathisic patients (n=30) with schizophrenia and healthy controls (n=30) because of the controversy in the association of iron and akathisia. The Barnes Akathisia Scale for akathisia and Simpson-Angus Rating Scale for extrapyramidal side effects were used. Serum iron and linked variables and hematological profile of the patients and control subjects were determined. Serum iron levels were significantly lower both in akathisic and non-akathisic groups compared to the control group (P<0.001). Moreover, akathisic patients had significantly lower iron levels than non-akathisic patients (P<0.05). Total iron binding capacity was significantly higher in patients with akathisia compared to the control group (P<0.01). Although non-akathisic patients had a mild increase in total iron binding capacity, it was not statistically significant compared to the control group (P>0.05). Ferritin levels were determined to be significantly lower in both groups compared to the control group (P<0.01). In addition, there was a significant difference in ferritin levels between the patients with and without akathisia (P<0.05). In conclusion, our results support the hypothesis that an association between akathisia and iron metabolism exists.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12650948     DOI: 10.1016/s0924-977x(02)00073-1

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  9 in total

1.  Improvement in neuroleptic-induced akathisia with intravenous iron treatment in a patient with iron deficiency.

Authors:  Paul E Cotter; Shaun T O'Keeffe
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-05       Impact factor: 10.154

Review 2.  Oxidative stress in schizophrenia: an integrated approach.

Authors:  Byron K Y Bitanihirwe; Tsung-Ung W Woo
Journal:  Neurosci Biobehav Rev       Date:  2010-10-23       Impact factor: 8.989

3.  Serum Ferritin, Weight Gain, Disruptive Behavior, and Extrapyramidal Symptoms in Risperidone-Treated Youth.

Authors:  Chadi A Calarge; Daryl J Murry; Ekhard E Ziegler; L Eugene Arnold
Journal:  J Child Adolesc Psychopharmacol       Date:  2016-02-19       Impact factor: 2.576

4.  Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychotic treatment.

Authors:  Maria Juncal-Ruiz; Mariluz Ramirez-Bonilla; Jorge Gomez-Arnau; Victor Ortiz-Garcia de la Foz; Paula Suarez-Pinilla; Obdulia Martinez-Garcia; Karl David Neergaard; Rafael Tabares-Seisdedos; Benedicto Crespo-Facorro
Journal:  Psychopharmacology (Berl)       Date:  2017-05-31       Impact factor: 4.530

5.  Incidence and predictors of acute akathisia in severely ill patients with first-episode schizophrenia treated with aripiprazole or risperidone: secondary analysis of an observational study.

Authors:  Bunta Yoshimura; Kojiro Sato; Shinji Sakamoto; Masaru Tsukahara; Yusaku Yoshimura; Ryuhei So
Journal:  Psychopharmacology (Berl)       Date:  2018-11-15       Impact factor: 4.530

6.  Comparative Study on Serum Levels of 10 Trace Elements in Schizophrenia.

Authors:  Tiebing Liu; Qing-Bin Lu; Lailai Yan; Jing Guo; Fangbo Feng; Jinyun Qiu; Jingyu Wang
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

Review 7.  Tardive Akathisia with Asymmetric and Upper-body Presentation: Report of Two Cases and Literature Review.

Authors:  Gholamali Shahidi; Mohammad Rohani; Renato Puppi Munhoz; Fahimeh H Akhoundi
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2018-05-29

8.  Latent Iron Deficiency as a Marker of Negative Symptoms in Patients with First-Episode Schizophrenia Spectrum Disorder.

Authors:  Sung-Wan Kim; Robert Stewart; Woo-Young Park; Min Jhon; Ju-Yeon Lee; Seon-Young Kim; Jae-Min Kim; Paul Amminger; Young-Chul Chung; Jin-Sang Yoon
Journal:  Nutrients       Date:  2018-11-08       Impact factor: 5.717

9.  Prevalence of iron deficiency in a South African adolescent inpatient psychiatric population: Rates, risk factors and recommendations.

Authors:  Theonie du Plessis; Karis Moxley; Anusha Lachman
Journal:  S Afr J Psychiatr       Date:  2019-07-16       Impact factor: 1.550

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.